4136

524396

BIOFILCHEM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

BIOFIL CHEM & PHARMA LTD Share Price Today

BIOFIL CHEM & PHARMA LTD is currently trading at ₹36.25, up by ₹0.84 from the previous close. The stock touched an intraday high of ₹37.50 and a low of ₹35.56 during the latest trading session. Over the past one year, BIOFIL CHEM & PHARMA LTD has delivered a loss of 32.81%, while the stock has gained 6.85% in the last one month.

BIOFIL CHEM & PHARMA LTD performance

Today’s low Today’s high
₹ 35.56 ₹ 37.50
₹ 36.25
52 week low 52 week high
₹ 25.60 ₹ 53.93
₹ 36.25
Open Price ₹ 36.30
Prev. Close ₹ 35.40
Volume (Shares) 234649.00
Total traded value ₹ 85.06
Upper Circuit ₹ 42.48
Lower Circuit ₹ 28.32
info

Investment Returns

Over 1 Month 6.85% Over 3 Months 15.83% Over 6 Months 4.39% Over 1 Year -32.81%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

BIOFIL CHEM & PHARMA LTD fundamentals


  • Market cap (Cr) 59.00
  • P/E Ratio (TTM) 20.86
  • Beta 0.90
  • Book Value / share 13.25
  • Return on equity 1.12%
  • EPS (TTM) 1.71
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.21
info icon alternate text
  • Market cap (Cr) 58.90
  • P/E Ratio (TTM) 20.86
  • Beta 0.79
  • Book Value / share 13.25
  • Return on equity 1.12%
  • EPS (TTM) 1.71
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.21
info icon alternate text

BIOFIL CHEM & PHARMA LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 7.57
Operating Expense 7.21
Net Profit 0.21
Net Profit Margin (%) 2.77
Earnings Per Share (EPS) 0.13
EBITDA 0.54
Effective Tax Rate (%) 55.31
Particulars DEC 2025 (Values in Cr)
Revenue 0.86
Operating Expense 0.83
Net Profit 0.08
Net Profit Margin (%) 9.30
Earnings Per Share (EPS) 0.05
EBITDA 0.18
Effective Tax Rate (%) 27.27
Particulars SEP 2025 (Values in Cr)
Revenue 13.54
Operating Expense 13.49
Net Profit 0.08
Net Profit Margin (%) 0.59
Earnings Per Share (EPS) 0.05
EBITDA 0.18
Effective Tax Rate (%) 27.27
Particulars JUN 2025 (Values in Cr)
Revenue 6.43
Operating Expense 6.50
Net Profit 2.41
Net Profit Margin (%) 37.48
Earnings Per Share (EPS) 1.48
EBITDA 2.83
Effective Tax Rate (%) 12.68
Particulars MAR 2025 (Values in Cr)
Revenue 8.35
Operating Expense 8.34
Net Profit 0.20
Net Profit Margin (%) 2.39
Earnings Per Share (EPS) 0.12
EBITDA 0.34
Effective Tax Rate (%) 20.00
Particulars MAR 2026 (Values in Cr)
Revenue 28.40
Operating Expense 28.03
Net Profit 2.79
Net Profit Margin (%) 9.82
Earnings Per Share (EPS) 1.71
EBITDA 3.73
Effective Tax Rate (%) 19.13
Particulars MAR 2025 (Values in Cr)
Revenue 33.40
Operating Expense 32.97
Net Profit 0.56
Net Profit Margin (%) 1.67
Earnings Per Share (EPS) 0.34
EBITDA 1.16
Effective Tax Rate (%) 24.32
Particulars MAR 2024 (Values in Cr)
Revenue 40.04
Operating Expense 39.66
Net Profit 0.71
Net Profit Margin (%) 1.77
Earnings Per Share (EPS) 0.44
EBITDA 1.31
Effective Tax Rate (%) 18.39
Particulars MAR 2023 (Values in Cr)
Revenue 30.04
Operating Expense 29.34
Net Profit 0.56
Net Profit Margin (%) 1.86
Earnings Per Share (EPS) 0.29
EBITDA 1.26
Effective Tax Rate (%) 29.11
Particulars MAR 2022 (Values in Cr)
Revenue 22.38
Operating Expense 21.52
Net Profit 0.70
Net Profit Margin (%) 3.12
Earnings Per Share (EPS) 0.44
EBITDA 1.48
Effective Tax Rate (%) 31.68
Particulars MAR 2025 (Values in Cr)
Book Value / Share 11.54
ROE % 1.12
ROCE % 1.55
Total Debt to Total Equity 0.02
EBITDA Margin 3.47
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.19
ROE % 1.42
ROCE % 1.81
Total Debt to Total Equity 0.03
EBITDA Margin 3.25
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.63
ROE % 1.12
ROCE % 1.65
Total Debt to Total Equity 0.03
EBITDA Margin 4.19
Particulars MAR 2022 (Values in Cr)
Book Value / Share 10.35
ROE % 1.40
ROCE % 2.11
Total Debt to Total Equity 0.03
EBITDA Margin 6.61
Particulars MAR 2021 (Values in Cr)
Book Value / Share 9.91
ROE % 2.49
ROCE % 3.92
Total Debt to Total Equity 0.05
EBITDA Margin 6.71
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 50.96
Total Liabilities 50.96
Total Equity 18.78
Share Outstanding 1
Price to Book Ratio 3.56
Return on Assets (%) 1.09
Return on Capital (%) 2.9
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.28
Total Assets 47.08
Total Liabilities 47.08
Total Equity 18.20
Share Outstanding 1
Price to Book Ratio 5.39
Return on Assets (%) 1.50
Return on Capital (%) 3.8
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 31.40
Total Liabilities 31.40
Total Equity 17.30
Share Outstanding 1
Price to Book Ratio 3.90
Return on Assets (%) 1.78
Return on Capital (%) 3.14
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 18.73
Total Liabilities 18.73
Total Equity 16.83
Share Outstanding 1
Price to Book Ratio 5.58
Return on Assets (%) 3.72
Return on Capital (%) 4.04
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.44
Total Assets 33.23
Total Liabilities 33.23
Total Equity 16.12
Share Outstanding 1
Price to Book Ratio 6.62
Return on Assets (%) 3.73
Return on Capital (%) 7.5
Particulars MAR 2025 (Values in Cr)
Net Income 0.73
Cash from Operations -1.74
Cash from Investing -0.10
Cash from Financing 0.00
Net change in Cash -2.02
Free Cash Flow -1.64
Particulars MAR 2024 (Values in Cr)
Net Income 0.86
Cash from Operations 2.54
Cash from Investing -0.02
Cash from Financing -0.12
Net change in Cash 2.24
Free Cash Flow 2.57
Particulars MAR 2023 (Values in Cr)
Net Income 0.79
Cash from Operations 0.12
Cash from Investing -0.01
Cash from Financing 0.01
Net change in Cash -0.10
Free Cash Flow 0.13
Particulars MAR 2022 (Values in Cr)
Net Income 1.01
Cash from Operations 0.09
Cash from Investing -0.06
Cash from Financing 0.00
Net change in Cash -0.29
Free Cash Flow 0.16
Particulars MAR 2021 (Values in Cr)
Net Income 1.91
Cash from Operations 1.78
Cash from Investing -0.09
Cash from Financing -0.83
Net change in Cash 0.18
Free Cash Flow 2.35
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.52 13.02 1.52 241.55 23.12 38.85
BLISS GVS PHARMA LTD. 436.05 35.28 3.86 4612.93 118.35 462.70
CIPLA LTD 1383.00 29.35 3.24 111725.01 1165.55 1672.20
FERMENTA BIOTECH LTD. 328.55 14.49 2.37 966.96 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2102.70 37.02 15.70 35621.01 2096.65 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.52 22.04 4.06 241.55 23.12 38.85
AMRUTAJAN HEALTH LTD 562.65 25.22 4.39 1626.66 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8248.80 107.73 23.62 20622.00 7630.00 10653.05
BLISS GVS PHARMA LTD. 436.05 46.89 3.99 4612.93 118.35 462.70

BIOFIL CHEM & PHARMA LTD shareholding pattern

Holding
53.12%
46.79%
0.08%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

BIOFIL CHEM & PHARMA LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
36.25 2.40 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 35.60
  • 26 Days 34.30
  • 10 Days 35.20
  • 50 Days 33.70
  • 12 Days 35.10
  • 100 Days 33.90
  • 20 Days 34.60
  • 200 Days 36.70
36.47 PIVOT
First Support 33.94 First Resistance 37.93 Second Support 32.48 Second Resistance 40.46 Third Support 29.95 Third Resistance 41.92
RSI 56.97 ADX 39.40 MACD 0.77 Williams % R -52.28 Commodity Channel Index (CCI) 89.63
Date 2026-06-11 Week 92870.00 Same Day 185810.00 Month 46654.00
1 Year 0.90 3 Year 1.19
Over 1 Month
6.85% down
Over 1 Year
-32.81% down
Over 3 Months
15.83% down
Over 3 Years
-7.48% down
Over 6 Months
4.39% down
Over 5 Years
-13.11% down

BIOFIL CHEM & PHARMA LTD Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Biofil Chemicals & Pharmaceuticals Ltd?

Answer Field

Biofil Chemicals & Pharmaceuticals Ltd share price is for NSE ₹ 36.25 & for BSE ₹ 36.20 as on Jun 12 2026 03:30 PM.

What is the Market Cap of Biofil Chemicals & Pharmaceuticals Ltd Share?

Answer Field

The market cap of Biofil Chemicals & Pharmaceuticals Ltd for NSE ₹ 59.00 & for BSE ₹ 0.00 as on Jun 12 2026 03:30 PM.

What is the 52 Week High and Low of Biofil Chemicals & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Biofil Chemicals & Pharmaceuticals Ltd for NSE is ₹ 53.93 and ₹ 25.60 and for BSE is ₹ 54.82 and ₹ 25.60.

What is 1 year return for Biofil Chemicals & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -32.81%.

What is the P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd Share?

Answer Field

As on Jun 12 2026 03:30 PM the price-to-earnings (PE) ratio for Biofil Chemicals & Pharmaceuticals Ltd share is 20.86.

What is the PB ratio of Biofil Chemicals & Pharmaceuticals Ltd Share?

Answer Field

As on Jun 12 2026 03:30 PM, the price-to-book (PB) ratio for Biofil Chemicals & Pharmaceuticals Ltd share is 13.25.

How to Buy Biofil Chemicals & Pharmaceuticals Ltd Share?

Answer Field

You can trade in Biofil Chemicals & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Biofil Chemicals & Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Biofil Chemicals & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Biofil Chemicals & Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|